Wikidata entity: Q425154
Quantities
| P4250 | defined daily dose | 20 |
| P3780 | active ingredient in | ... | Q29006460 (Roactemra) | Roactemra |
| P1552 | has characteristic | ... | Q679692 (biopharmaceutical) | biopharmaceutical |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P176 | manufacturer | ... | Q212646 (Hoffmann-La Roche) | Hoffmann-La Roche |
| P2175 | medical condition treated | ... | Q170990 (arthritis) | arthritis |
| P2175 | medical condition treated | ... | Q432462 (Takayasu's arteritis) | Takayasu's arteritis |
| P2175 | medical condition treated | ... | Q707816 (giant cell arteritis) | giant cell arteritis |
| P2175 | medical condition treated | ... | Q1274464 (polyarthritis) | polyarthritis |
| P2175 | medical condition treated | ... | Q1752891 (polymyalgia rheumatica) | polymyalgia rheumatica |
| P2175 | medical condition treated | ... | Q1947302 (Castleman's disease) | Castleman's disease |
| P2175 | medical condition treated | ... | Q17148432 (systemic-onset juvenile idiopathic arthritis) | systemic-onset juvenile idiopathic arthritis |
| P2175 | medical condition treated | ... | Q84263196 (COVID-19) | COVID-19 |
| P5008 | on focus list of Wikimedia project | ... | Q87748614 (WikiProject COVID-19) | WikiProject COVID-19 |
| P127 | owned by | ... | Q212646 (Hoffmann-La Roche) | Hoffmann-La Roche |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q422248 (monoclonal antibody) | monoclonal antibody |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | tocilizumab | ??? |
| P267 | ATC code | L04AC07 |
| P268 | Bibliothèque nationale de France ID | 16764118r |
| P231 | CAS Registry Number | 375823-41-9 |
| P592 | ChEMBL ID | CHEMBL1237022 |
| P715 | DrugBank ID | DB06273 |
| P646 | Freebase ID | /m/027yz2q |
| P595 | Guide to Pharmacology Ligand ID | 6881 |
| P269 | IdRef ID | 178144762 |
| P665 | KEGG ID | D02596 |
| P7830 | LiverTox ID | Tocilizumab |
| P10245 | MedlinePlus drug identifier | a611004 |
| P6366 | Microsoft Academic ID (discontinued) | 2777178219 |
| P2115 | NDF-RT ID | N0000180629 |
| P3222 | NE.se ID | tocilizumab |
| P10283 | OpenAlex ID | C2777178219 |
| P3345 | RxNorm CUI | 612865 |
| P4527 | UK Parliament thesaurus ID | 468363 |
| P652 | UNII | I031V2H011 |
| P11143 | WikiProjectMed ID | Tocilizumab |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 8394 |
Why not click here or view trends?
log id: 2025514